SOX11 was previously reported in a varying number of glial neoplasms, ranging from 93–100% of astrocytomas, using polyclonal antibody [18], to a more limited 50% of gliomas when monoclonal antibody MRQ-58 was used. The gene discussed is SOX11; the disease is astrocytoma (excluding glioblastoma).